STAT+: Abridge inks deals with Nvidia and Lilly

STAT PlusHealth tech Abridge inks deals with Nvidia and Lilly The well-funded maker of AI scribes aims to beef up its technology and expand ties to pharma Manage alerts for this article Email this article Share this article By Mario AguilarJune 11, 2026 Health Tech Correspondent Mario Aguilar[email protected]Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer wearables. He’s also the co-author of the free, twice weekly STAT Health Tech newsletter. You can reach Mario on Signal at mariojoze.13. NEW YORK — Health care artificial intelligence company Abridge on Thursday announced new deals with two trillion-dollar companies, pharma giant Eli Lilly and chipmaker Nvidia, as it aims to gain an edge in the competitive market for software that supports doctors and streamlines hospital billing and operations. Abridge devoted much of a midtown Manhattan event to demonstrating new and streamlined elements of its platform that documents patient visits and offers guidance and suggestions to clinicians before, during, and after a visit.Advertisement But the billboard announcements were partnerships. Draped head-to-toe in black, on a day forecast to be in the 90s, Abridge CEO Shiv Rao announced that Eli Lilly would make a strategic investment in the company and a new collaboration with Nvidia to develop “the first foundation model purpose-built for clinical conversations.” STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+. Already have an account? Log in Monthly $39 Totals $468 per year $39/month Get Started Totals $468 per year Starter $30 for 3 months, then $399/year $30 for 3 months Get Started Then $399/year Annual $399 Save 15% $399/year Get Started Save 15% 11+ Users Custom Savings start at 25%! Request A Quote Request A Quote Savings start at 25%! 2-10 Users $300 Annually per user $300/year Get Started $300 Annually per user View All Plans To read the rest of this story subscribe to STAT+. Subscribe Log In Artificial intelligence, health tech, STAT+ Submit a correction requestReprints Mario Aguilar Health Tech Correspondent Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer wearables. He’s also the co-author of the free, twice weekly STAT Health Tech newsletter. You can reach Mario on Signal at mariojoze.13. Newsletter Tech is transforming health care and life sciences. Our original reporting is here to keep you ahead of the curve. Recommended Health Tech Newsletter June 11, 2026 STAT Plus: AMA and lawmakers push back on AI care denials Health June 11, 2026 Nonprofit buys experimental cancer drug to maintain patient access Advertisement Health June 11, 2026 Study highlights influence of socioeconomic status on children’s brain development D.C. Diagnosis June 11, 2026 STAT Plus: A suspicious denial pattern in Medicare Advantage The Readout June 11, 2026 STAT Plus: Novartis doubles down on molecular glue strategy Subscriber Picks